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Abstract: 
The aerobic gram positive bacterium Corynebacterium diphtheriae causes diphtheria, a respiratory tract illness characterized by 
symptoms such as sore throat, low fever, and an adherent membrane on the tonsils, pharynx, and/or nasal cavity. Therefore, it is 
important to develop preventive vaccines for diphtheria. The availability of the 2,488,635 bp long complete sequence for the C. 
diphtheriae genome provides an opportunity to understand cell mediated immune response using Computational Biology tools 
from the bacterial proteome sequence data. We selected 355 membrane proteins from the C. diphtheriae proteome using 
annotation data to identify potential HLA-DRB1 binding short peptide using modeling, simulations and predictions. This exercise 
identified 30 short peptides in membrane proteins showing binding capability to HLA-DRB1 alleles. These peptides serve as 
outline for the understanding of cell mediated immune response to C. diphtheriae. It should be noted that the predicted data to be 
verified using binding assays for further consideration. 
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Background: 
Diphtheria is an epidemic disease that remains as a threat 
to health in the developing world [1]. The diphtheria 
epidemic had caused more than 157,000 cases and 5000 
deaths according to WHO reports [2]. Diphtheria is caused 
by Corynebacterium diphtheriae, a non-sporulating, non-
encapsulated, non-motile, pleomorphic gram-positive 
bacillus. The complete genome of the living organism 
Corynebacterium diphtheriae was sequenced [3]. The 
sequence and annotation of genome is available in 
DDBJ/EMBL/GenBank databases with the accession 
number BX248353. Immunization leads to the 
disappearance of toxigenic strains, but toxigenicity can be 
rapidly conferred on non-toxigenic strains via phage 
conversion. This makes the return of epidemic diphtheria a 
real threat when there is insufficient immunity. Hence, it is 
crucial and critical develop vaccines for diphtheria. 
Identification of potential peptide candidates for vaccine 
development have been shown using computational 
methods for pathogenic organisms elsewhere [4]. The 
application of proteome sequence data and Bioinformatics 
tool for the development of peptide vaccines for infectious 
diseases has gained momentum in recent years [5]. 
 
C. diphtheriae virulence factors, other than diphtheria toxin 
can be the potential cause to the disease. Recently, surface 
proteins of 67 and 72kDa, named 67-72p were isolated and 
related to the attachment of C. diphtheria to the human 
erythrocytes  [1]. The pathogenicity island of the organism 
encode vast majority of fimbria and iron uptake system. The 
fimbrial system show similarities to sortases bound to surface 
proteins and are considered as pathogenicity factor [3]. It can be 
drawn that membrane related proteins could have pathogenicity 
property. The efficacy of immune response is associated with 
antigen specificity, diversity and human leukocyte antigen 
(HLA) alleles. [6]. There are two classes of HLA molecules, 
namely class I and class II that are recognized for two distinct 
sets of T cells, the CD8
+ and CD4
+ T cells, respectively [7, 8]. 
There are evidences suggesting the association of diphtheriae 
antigen with class II alleles. [9] Nonetheless, the HLA 
molecules are highly polymorphic and there are more than 800 
class II HLA alleles known till date [10]. Here, we describe the 
identification of potential peptides in the membrane proteins of 
C. diphtheriae binding to HLA DRB1*0101, DRB1*0301, 
DRB1*0401, DRB1*0701, DRB1*1801, DRB1*1101 and 
DRB1*1501 using predictions, modeling and simulations. It 
should be noted that these alleles have an allelic frequency of 
20-50% [11] 
 
Methodology: 
C. diphtheriae membrane protein dataset 
The whole genome sequence of C. diphtheriae with annotated 
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with accession number BX248353. The genome is 
2,488,635 bp long containing 2320 CDS with about 53.5% 
G+C content [3]. The annotated protein sequences for 
membrane or associated proteins that are annotated as 
putative ABC transport membrane protein, integral 
membrane protein, membrane protein, fimbrial protein, 
surface anchored protein and hypothetical membrane 
protein. Thus, we created a membrane protein dataset from 
C. diphtheriae with 355 sequences (list available from 
authors upon request). 
 
Prediction of antigenic regions in membrane proteins 
It is important to identify antigenic regions in the 355 
membrane or associated proteins in C. diphtheriae. The 
antigenic subsequences from the membrane proteins were 
identified using the Antigenic server in EMBOSS GUI 
version 1.12 [12]. The server uses a semi-empirical method 
for the prediction of antigenic regions in a protein based on 
the physiochemical properties of amino acids and their 
frequency of occurrence in experimentally known 
segmental epitopes as described elsewhere [13]. The 
stringency level is enhanced by keeping 2.3 as a cut-off 
value. Peptide sequences with less than 9 residues were 
ignored as class 2 HLA molecules bind peptides of length 
12-15 residues long [14]. Thus, we identified 1448 
antigenic regions from the 355 membrane proteins. 
However, we further reduced the set to 30 based on 
antigenic score obtained from the server (Table 1 under 
supplementary material). We used this dataset for HLA 
binding peptides as described in the next section. 
.  
Prediction of T-cell peptides  
PROPRED server [15] was used for the prediction of MHC 
class II HLA DRB1 allele binding regions in the identified 
antigenic regions (Table 1 under supplementary material). 
The server employs amino acid position coefficient tables 
deduced from literature by linear prediction model [16]. A 
threshold of 3% was fixed to reduce the rate of false 
positives. Prediction were performed for alleles 
DRB1*0101, 0401 and 1501.We restricted our analysis to 
these alleles due to availability of structures determined by 
X-ray crystallography at the protein databank (PDB). 
 
Discussion: 
The availability of the completely sequenced genome of C. 
diphtheriae provides an opportunity to understand 
pathogenicity using a genome wide scanning and analysis. 
The annotated genome of C. diphtheriae contains 2320 
CDS. We identified 355 membrane proteins using 
annotated protein information the dataset. This accounts for 
only 15% of the genome CDS. The corresponding protein 
sequences of 355 proteins were used as a dataset for the 
identification of peptide antigenic regions using ANTIGEN 
and PROPRED servers. The ANTIGEN server uses 
physiochemical properties of amino acids to determine 
antigen region regions in the membrane protein dataset. 
This exercise resulted in about 1448 short segments of 
length 9 or more from the 355 membrane proteins. The least 
score for the predicted antigenic peptide sequence is found to be 
0.92 and the maximum score is 3.09. The minimum length of 
the peptide is kept as 9 residues in the parameter selection. The 
antigenic peptide sequences up to a maximum length of 54 
residues were obtained.  
 
The data on immunogenic to C. diphtheriae antigen is limited 
except for some sporadic data. We further reduced this number 
to 30 segments using antigenicity score obtained from 
ANTIGEN (Table 1 in supplementary material). This set of 
peptides is used for the screening of potential binding to HLA 
DRB1*0101, 0401 and 1501 using PROPRED. These alleles 
have coverage of about 20-150% among different populations 
[11].The screening of peptide bindings to HLA DRB1*0101, 
0401 and 1501 using PROPRED identified a list of peptides 
with positive binding scores (Table 1, see supplementary 
material). This list of peptides provides a framework for further 
investigation of C. diphtheriae towards the development of 
vaccine candidates. Subunit vaccines consisting of diphtheriae 
protein antigens present a safe and specific tool for the 
prevention of Diphtheria. The identification of promiscuous 
binding to HLA is an ideal prerequisite for the design of subunit 
vaccines. It should be noted that these are predicted data 
requiring validation using binding assays. The current challenge 
in synthetic vaccine design is the development of a 
methodology to identify and test short antigen peptides as 
potential T-cell epitopes. Data driven statistical methods such as 
PROPRED are generally available for class II DR1, and DR4. 
Reliable predictions of immunogenic peptides can reduce the 
experimental effort needed to identify new epitopes, and though 
reliable predictions of the MHC binding can be used to rank the 
possible epitopes very accurately. In this paper we have tried to 
accurately predict antigenic peptides using PROPRED which is 
a tool used to predict the MHC binding peptides. Class II MHC 
binding predictions need to develop a greater accuracy level, 
but new tools have emerged that deliver significantly improved 
predictions not only in terms of accuracy, but also in MHC 
specificity coverage. The future development of advanced tools 
using structured based features will significantly improve the 
efficiency of prediction for high true positives considerations. 
 
Conclusion: 
The scanning of immunologically relevant regions of the 
bacterial proteome sequence of C. diphtheriae is essential in the 
identification of specific HLA binding peptides for potential 
design of vaccine candidates for diphtheria. Here, we identified 
30 segments using ANTIGEN at EMBOSS for further 
screening of these peptides to PROPRED for DRB1*0101, 
0401 and 1501 specific binding. The specific segments showing 
positive binding score with each of these alleles is presented for 
further investigations using modeling towards in vitro 
investigations. 
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Supplementary material 
  Allele  GenBank ID  Peptide*  PROPRED Binding Score 
1 CAE49048  LRILLAVAV  76.67 
2 CAE50605  FVALIGVSI  68.33 
3 CAE49825  VRMLVATYV  64.83 
4 CAE49471  FVLLLAKLM  64.67 
5 CAE50256  VVLIVAVPL  63.33 
6 CAE50851  YVLAIAVLA  63.33 
7 CAE50475  FLINVPVVI  62.33 
8 CAE48920  LVLIAAIVL  61.67 
9 CAE49353  IVLLPCVVA  61.67 
10 
DRB*0101 
 
CAE48741 LVMLYPVTS  60.00 
11 CAE50577  VVLSVVLLS  60.47 
12 CAE50281  FVVSIVLIA  58.14 
13 CAE50864  VFLTTTLLS  55.81 
14 CAE49353  VIIIASLVS  55.81 
15 CAE49135  VRLIDVIVS  54.42 
16 CAE48741  LVILGVLVM  53.49 
17 CAE50652  VLLSVTVGS  52.09 
18 CAE50802  WVFLSACIS  51.16 
19 CAE48779  FIGLNVLLS  51.16 
20 
DRB*0401 
 
CAE48675 VVILGVIVA  50.93 
21 CAE48779  VVAYPRLPL  81.63 
22 CAE50888  VVYFLLLLV  78.57 
23 CAE50670  VVIFAASTI  71.43 
24 CAE49665  IVFFVAMVA  71.43 
25 CAE48521  VILYFGMQA  69.39 
26 CAE50218  VVIFHCFVG  67.35 
27 CAE48598  LVNYVGHDV  66.33 
28 CAE50340  IVLLAGLSL  66.33 
29 CAE50810  LRFIVGLGL  66.33 
30 
DRB*1501 
 
CAE50855 LVLLVGLAV  64.49 
Table 1: Predicted peptides binding to HLA DRB1*0101, 0401 and 1501. (*The anchoring region in class 2 HLA molecules lies 
within 9 residues window. These peptides were selected by both ANTIGEN and PROPRED). 